Clinical Trials on Lentivirus Infections

Total 56834 results

University of California, Los Angeles
Brown University; Asociación Civil Impacta Salud y Educación, Peru; The Fenway...

Completed

TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru (TransPrEP)

HIV Infection

Peru
University of British Columbia

Completed

Switch to Unboosted Atazanavir With Tenofovir Study (SUAT)

HIV Infection

Canada
University of Zurich
Merck Sharp & Dohme LLC; Swiss HIV Cohort Study

Completed

Raltegravir in the Swiss HIV Cohort Study

HIV Infection

Switzerland
Harvard School of Public Health (HSPH)
International Initiative for Impact Evaluation; Uganda Health Marketing Group; International Research Consortium

Completed

Impact of HIV Self-testing Among Female Sex Workers in Kampala, Uganda (HSPOT)

HIV Infection
Incyte Corporation

Completed

Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients

HIV Infections

United States
University of North Carolina, Chapel Hill
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

HIV Infection

United States
University of British Columbia

Terminated

Pilot Study of Diflunisal in HIV-infected Adults

HIV Infection

Canada
National Institute of Allergy and Infectious Diseases...

Completed

Analysis of HIV Genetic Variation in Patients Before Beginning Highly Active Antiretroviral Therapy

HIV Infection

United States
Abivax S.A.

Completed

ABX464 in Fully Controlled HIV Infected Patients Treated With Boosted Protease Inhibitor Treatment

HIV Infection

Spain, Belgium, France
The University of Texas Health Science Center,...

Completed

Study of Cell Phone SMS to Improve Adherence to ART in HIV Positive Young Women

HIV Infection

United States
ANRS, Emerging Infectious Diseases

Completed

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment (COPANA)

HIV Infection

France
HIV Prevention Trials Network
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies

HIV Infection

United States
Merck Sharp & Dohme LLC

Terminated

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)

HIV Infection
Merck Sharp & Dohme LLC

Terminated

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

HIV Infection
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

Connect to Protect Partnerships for Youth Prevention Interventions: Phase II

HIV Infection

United States, Puerto Rico
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute of Mental Health...

Completed

Enhancement of Connect to Protect® (C2P)

HIV Infection

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Terminated

Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers

HIV Infection

United States
ANRS, Emerging Infectious Diseases

Unknown

Third Line Antiretroviral Treatment Optimization in Sub-Saharan Africa (THILAO)

HIV Infection

Burkina Faso, Côte D'Ivoire, Mali, Senegal
Fundacion SEIMC-GESIDA
Janssen, LP

Completed

Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject (DUAL)

HIV Infection

Spain
Aghia Sophia Children's Hospital of Athens

Unknown

Immunological Memory Induced by the 13valent Pneumococcal Conjugate(PCV13) and 23valent Plain Polysaccharide Vaccine(PPV23) in HIV-infected Patients

HIV Infection
Argos Therapeutics

Completed

Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

HIV Infection

United States, Canada
ANRS, Emerging Infectious Diseases

Completed

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients (ANRS EP 52)

Hiv Infection

France
Catholic University of the Sacred Heart

Terminated

Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA) (GUSTA)

HIV Infection

Italy
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

HIV Infection

United States
Center for Primary Care and Public Health (Unisante)...
Centre Hospitalier Universitaire Vaudois; Swiss HIV Cohort Study

Completed

HIV Disclosure and Medication Adherence, a Pilot Study (RSAD-VIH-11)

HIV Infection

Switzerland
Harvard School of Public Health (HSPH)
Harvard Medical School (HMS and HSDM); Centers for Disease Control and Prevention and other collaborators

Completed

Positive Change Agents Program-Tanzania (Evaluation)

HIV Infection

Tanzania
Viriom

Completed

Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers

HIV-infection

Russian Federation
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX (imPACT)

HIV Infection

United States
US Department of Veterans Affairs

Completed

A Medication Adherence Intervention for HIV Infected Veterans

HIV Infection

United States
Hospital Clinic of Barcelona

Completed

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

HIV Infection

Spain
International Medical Center of Japan
Ministry of Health, Labour and Welfare, Japan

Completed

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

HIV Infection

Japan
Robert L. Murphy
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

Therapeutic Intensification Plus Immunomodulation to Decrease the HIV-1 Viral Reservoir (EraMune02)

HIV Infection

United States
AIDS Clinical Trials Group
Bristol-Myers Squibb; National Institute of Allergy and Infectious Diseases... and other collaborators

Completed

Comparative Study of Three NNRTI-Sparing HAART Regimens

HIV Infection

United States, Puerto Rico
Juan A. Arnaiz

Completed

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression (OLE)

HIV Infection

Spain
Dmitry Kireev
Pfizer

Completed

Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools (CoTrAST)

HIV Infection

Russian Federation
Centers for Disease Control and Prevention
San Francisco Department of Public Health; AIDS Research Consortium of Atlanta

Completed

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

HIV Infection

United States
Hospital Clinic of Barcelona

Completed

Dendritic Cell Vaccine in HIV-1 Infection

HIV Infections

Spain
Calmy Alexandra
Janssen-Cilag A.G., Switzerland

Completed

Prospective Evaluation of Etravirine for HIV-infected Patients in Need of Lipid-lowering Drugs (ETRALL)

HIV Infection

Switzerland
Kirby Institute
Imperial College London

Completed

The Efavirenz (EFV) Central Nervous System Exposure Sub-study of Encore1 (ENCORE1-CNS)

HIV Infection

Thailand, Germany, United Kingdom
International AIDS Vaccine Initiative
Children's Hospital of Philadelphia; Nationwide Children's Hospital; Targeted...

Completed

Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine (A001)

HIV Infection

Belgium, Germany, India
French National Agency for Research on AIDS and...

Completed

Residual Risk Assessment Of HIV Transmission (EP 49 EVARIST)

HIV Infection

France
Pedro Cahn
Abbott

Completed

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects. (GARDEL)

HIV Infection

Argentina
International Partnership for Microbicides, Inc.

Withdrawn

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

HIV Infections

South Africa, Malawi, Rwanda, Zimbabwe
St Stephens Aids Trust

Completed

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study (SSAT043)

HIV Infection

United Kingdom
Bristol-Myers Squibb

Completed

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

HIV Infection

South Africa, Puerto Rico, United States
Avexa

Completed

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

HIV Infection

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

HIV Infection
Pfizer

Completed

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

HIV Infection

United States, Canada
Western University of Health Sciences
Jeffrey Goodman Clinic, LA Gay & Lesbian Center

Completed

Pharmacokinetic Evaluation of Changes in Nevirapine AUC Due to Differences in Weight (NAWS)

HIV Infection

United States
GlaxoSmithKline

Terminated

Screening Protocol To Determine Eligibility For Studies Of The Chemokine Coreceptor 5 (CCR5) Antagonist GW873140

HIV Infection

United States, Germany, Belgium, Canada, Denmark

Clinical Trials on Lentivirus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations